Suppliers / Paxal Pharmaceuticals - India

Paxal Pharmaceuticals - India

8 employees Updated 9 July 2026

Paxal Pharmaceuticals - India is a finished-dose manufacturer. It appears in 15 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
15
filings across 1 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
EDA (EG) 15 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Paxal Pharmaceuticals - India

Does Paxal Pharmaceuticals - India hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Paxal Pharmaceuticals - India. It does have 15 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Paxal Pharmaceuticals - India file?
Filings are on record with EDA (EG), 15 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Paxal Pharmaceuticals - India comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability